Telik share price plummets after cancer drug failure
Shares in Telik plummeted after they reported their most advanced drug candidate failed three clinical trials, leaving analysts asking why they did not find out sooner.
Archives for January 3, 2007
Dishman Pharma has its eyes set on biotech CRO companies
India's Dishman Pharmaceuticals & Chemicals is planning to snap up biotech and nanotech contract research organisation (CRO) companies in Europe and in the US within drug conjugates to expand their biologics capability.
Neural stem cells target drug delivery
Neural stem cells (NSCs) engineered to express therapeutic molecules have shown dramatic efficacy against metastatic cancers in pre-clinical trials.
LAB Research expands preclinical testing in Canada
LAB Research has completed a $12m facility expansion in Canada that will increase its preclinical testing services capacity at the site by 40 per cent.
China aims for outsourcing supremacy
The Chinese government has announced plans to consolidate their outsourcing industry in an effort to capture business from other developing countries such as India.
Portable drug anti-counterfeiting device to hit market
The pharmaceutical industry's first fully portable drug anti-counterfeiting device will be presented in Baltimore later this month at IFPAC, the International Forum on Process Analytical Chemistry.
US biotech boom to benefit CROs
The booming biotech industry in the US is set to boost drug discovery business for contract research organisations (CROs) across the globe.
PerkinElmer snaps up Triton's thermal analysis line
PerkinElmer has announced its acquisition of a line of Dynamic Mechanical Analysis (DMA) products from UK-based firm Triton Technology in its latest move following a busy year of purchases during 2006.
Temperature-sensing RFID chip could cut shipment losses
A new radio frequency identification (RFID) tag for temperature-monitoring purposes has been developed for pharmaceutical products during transportation, where fluctuations in temperature can alert the logistics chain of impending disasters.
Chewable contraceptive for US women
A US pharmaceutical last month introduced a spearmint-flavoured chewable contraceptive pill as a 'more convenient' option for women 'on-the-go'.
Tripos to dissolve after Discovery Research sale
Tripos has agreed to sell its UK-based Discovery Research business to US-based drug discovery company Provid Pharmaceuticals for $2m (€1.5m).
Alzheimer's diagnostic could advance drug development
Researchers at UCLA in the USA have developed the first non-invasive diagnostic test for Alzheimer's disease.
GAO bemoans lack of new drugs
A US government report has warned that the pharmaceutical industry is not producing enough new drugs despite spending more on research and development.